What is Orexo?
Orexo is a pharmaceutical and digital therapy company dedicated to addressing critical unmet needs in the areas of substance use disorders and mental health. The company's innovative product pipeline, which includes both improved pharmaceuticals and digital therapeutics, is commercialized globally through direct operations in the US and strategic partnerships worldwide. Established in 1995 and headquartered in Uppsala, Sweden, Orexo has built a robust foundation for growth and development in these complex therapeutic areas.
How much funding has Orexo raised?
Orexo has raised a total of $141.7M across 4 funding rounds:
Series B
$22.4M
Stock Offering
$35.7M
Debt
$30M
Debt
$53.6M
Series B (2003): $22.4M with participation from Auriga Partners, Crédit Lyonnais Private Equity, Apex Venture Partners, HealthCap Partners, and Sofinnova Ventures
Stock Issuance/Offering (2005): $35.7M led by Undisclosed
Debt (2013): $30M supported by Danske Bank
Debt (2014): $53.6M featuring Undisclosed
Key Investors in Orexo
Auriga Partners
Auriga Partners is a venture capital firm that likely focuses on investing in innovative companies within the technology and healthcare sectors, providing strategic capital to fuel growth and market penetration.
Apex Venture Partners
Apex Venture Partners is an investment firm specializing in providing capital for companies, potentially with a focus on early-stage or growth-stage ventures across various industries.
Sofinnova Ventures
Sofinnova Ventures is a prominent venture capital firm with a strong specialization in life sciences, actively investing in transformative innovations across the healthcare and sustainability sectors from seed to later stages.
What's next for Orexo?
The recent major strategic investment signifies Orexo's transition into a scaling phase, likely enabling the company to expand its commercial reach, further develop its digital therapy platforms, and potentially pursue new research and development initiatives. This capital will be instrumental in solidifying Orexo's market position and accelerating its mission to improve patient outcomes in substance use disorders and mental health.
See full Orexo company page
